Breast cancer recurrence and metastatic spread explained Isra Zaman7 Sept 2022 9:15 AM ISTResearchers from the University of Cincinnati and Cincinnati Children's Hospital Medical Center are studying the biology of breast cancer recurrence....
Setback: HC rejects Sun Pharma plea against Hetero alleging trademark infringement of cancer drug Letroz Farhat Nasim6 Sept 2022 5:33 PM ISTNew Delhi: Holding that when the name is derived or coined from the name of the principal ingredient being used in the manufacture of the drug, no...
Breast tissue features on MRI may illuminate risk of second breast cancer Dr. Kamal Kant Kohli31 Aug 2022 8:00 PM ISTAdvanced in Breast cancer treatment and early detection has increased survival among women but still these women face an increased risk of...
Medical Bulletin 31/August/2022 Isra Zaman31 Aug 2022 3:09 PM ISTHere are the top medical news for the day:Second breast cancer risk highlighted by Breast MRIAccording to a study that was published in Radiology, a...
Second breast cancer risk highlighted by Breast MRI Isra Zaman31 Aug 2022 9:15 AM ISTAccording to a study that was published in Radiology, a publication of the Radiological Society of North America, breast tissue characteristics that...
AstraZeneca, MSD get Japenese nod for breast cancer drug Lynparza Ruchika Sharma28 Aug 2022 11:45 AM ISTBreast cancer is the most diagnosed cancer worldwide with an estimated 2.3 million patients diagnosed in 2020.
Breast cancer patients on fertility preservation measures don't entail increased risk of disease recurrence or death Dr. Kamal Kant Kohli26 Aug 2022 8:00 PM ISTMany women with hormone-positive breast cancer opt out of the procedures for fertility preservation because of the fear that these procedures...
AstraZeneca anticancer drug Trastuzumab Deruxtecan protocol amendment proposal approved by CDSCO panel Roshni Dhar23 Aug 2022 6:30 PM ISTBased on the justification provided by the pharma major AstraZeneca, the Subject Expert Committee(SEC) functional under Central Drug Standard Control...
Justify protocol amendments in detail: CDSCO Panel tells Eli Lilly on Trail of Imlunestrant Dr. Divya Colin23 Aug 2022 6:00 PM ISTNew Delhi: In response to the proposed protocol amendment for Eli Lilly's anticancer drug LY348-4356 (Imlunestrant), the Subject Expert Committee...
Health Bulletin 23/August/2022 Roshni Dhar23 Aug 2022 5:18 PM ISTHere are the top health news for the day:'Tomato fever' misleading colloquial name for hand, foot and mouth disease Medical professional has informed...
AstraZeneca India breast cancer drug lynparza gets DCGI okay Isra Zaman22 Aug 2022 5:15 PM ISTAstraZeneca India, a science-led biopharmaceutical company, has announced that it has received a Drugs Controller General of India (DCGI) approval to...
DCGI nod to AstraZeneca India breast cancer drug Lynparza Ruchika Sharma20 Aug 2022 11:49 AM ISTEarly breast cancer is defined as the cancer confined to the breast with or without regional lymph node involvement and the absence of distant...
